Adicet Bio, Inc. (ACET)
4.57
-0.57
(-11.09%)
USD |
NASDAQ |
Oct 16, 16:00
4.60
+0.03
(+0.66%)
After-Hours: 20:00
Adicet Bio Market Cap : 42.78M for Oct. 16, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 16, 2026 | 42.78M |
| October 15, 2026 | 48.12M |
| October 14, 2026 | 45.78M |
| October 13, 2026 | 47.84M |
| October 12, 2026 | 51.77M |
| October 09, 2026 | 52.52M |
| October 08, 2026 | 53.73M |
| October 07, 2026 | 57.85M |
| October 06, 2026 | 58.51M |
| October 05, 2026 | 60.57M |
| October 02, 2026 | 60.85M |
| October 01, 2026 | 62.16M |
| September 30, 2026 | 66.84M |
| September 29, 2026 | 63.94M |
| September 28, 2026 | 59.44M |
| September 25, 2026 | 84.44M |
| September 24, 2026 | 77.42M |
| September 23, 2026 | 79.48M |
| September 22, 2026 | 85.61M |
| September 21, 2026 | 83.60M |
| September 18, 2026 | 85.94M |
| September 17, 2026 | 84.35M |
| September 16, 2026 | 84.72M |
| September 15, 2026 | 79.62M |
| September 14, 2026 | 90.81M |
| Date | Value |
|---|---|
| September 11, 2026 | 89.12M |
| September 10, 2026 | 89.21M |
| September 09, 2026 | 89.31M |
| September 08, 2026 | 91.09M |
| September 04, 2026 | 89.78M |
| September 03, 2026 | 88.28M |
| September 02, 2026 | 86.69M |
| September 01, 2026 | 86.69M |
| August 31, 2026 | 81.44M |
| August 28, 2026 | 84.81M |
| August 27, 2026 | 84.35M |
| August 26, 2026 | 83.78M |
| August 25, 2026 | 84.25M |
| August 24, 2026 | 83.32M |
| August 21, 2026 | 86.03M |
| August 20, 2026 | 87.81M |
| August 19, 2026 | 88.84M |
| August 18, 2026 | 85.28M |
| August 17, 2026 | 81.82M |
| August 14, 2026 | 78.45M |
| August 13, 2026 | 77.33M |
| August 12, 2026 | 77.33M |
| August 11, 2026 | 77.04M |
| August 10, 2026 | 75.92M |
| August 07, 2026 | 74.70M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.291B |
| Alnylam Pharmaceuticals, Inc. | 31.00B |
| Anika Therapeutics, Inc. | 267.39M |
| Savara, Inc. | 914.03M |
| Vericel Corp. | 2.053B |
Market Cap Related Metrics
| PEG Ratio | -0.1287 |
| Price to Book Value | 0.3561 |
| Price | 4.57 |
| Earnings Yield | -252.4% |
| PEGY Ratio | -0.1287 |